Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissues

European Journal of Cancer

Volumn 35, Issue 2, 1999, Pages 320-324

  Lopez De Cerain A ^a   Marin A ^a   Idoate, M A ^a   Tunon M T ^b   Bello, J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Bioreductive agents; Breast tumour; Carbonyl reductase; Lung tumour; NAPDH P450 reductase

Indexed keywords

CARBONYL REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; TUMOR BIOPSY;

ALCOHOL OXIDOREDUCTASES; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEOPLASM PROTEINS;

EID: 0033083376     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00372-4     Document Type: Article

References (31)

1. Martin J.M., Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58:1998;1408-1416.
2. Miller V.A., Ng K.K., Grant S.C., et al. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol. 8:1997;1269-1271.
3. Pavlidis N., Hanauke A.R., Gamucci T., et al. A randomized phase II study with two schedules of the novel indoloquinone E09 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG). Ann Oncol. 7:1996;529-531.
4. Bedikian A.Y., Legha S.S., Eton O., et al. Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma. Ann Oncol. 8:1997;363-367.
5. Workman P., Stratford I.J. The experimental development of bioreductive drugs and their role in cancer therapy. Cancer Metastasis Rev. 12:1993;73-82.
6. Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J Biol Chem. 256:1981;1206-1213.
7. Nakayama T., Hara A., Yashiro K., Sawada H. Reductases from carbonyl compounds in human liver. Biochem Pharmacol. 34:1985;107-117.
8. Inazu N., Ruepp B., Wirth H., Wermuth B. Carbonyl reductase from human testis: purification and comparison with carbonyl reductase from human brain and rat testis. Biochem Biophys Acta. 116:1992;50-56.
9. Wirth H., Wermuth B. Immunohistochemical localization of carbonyl reductase in human tissues. J Histochem Cytochem. 42:1992;1857-1863.
10. Lee S.C., Levine L. Prostaglandin metabolism I. Cytoplasmic reduced nicotinamide adenine dinucleotide phosphate-dependent and microsomal reduced nicotinamide adenine dinucleotide-dependent prostaglandin E9-ketoreductase activities in monkey and pigeon tissues. J Biol Chem. 249:1974;1369-1375.
11. Ahmed N.K., Felsted R.L., Bachur N.R. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers. Biochem Pharmacol. 27:1978;2713-2719.
12. Wermuth B., Platts K.L., Seidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxification in man. Biochem Pharmacol. 35:1986;1277-1282.
13. Ohara H., Miyabe Y., Deyashiki Y., Matshura K., Hara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. J Biochem. 50:1995;221-227.
14. Lloyd R.V., Duling D.R., Rumyantseva G.V., Mason R.O., Bridson P.K. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. Molec Pharmacol. 40:1991;440-445.
15. Wang J., Biederman K.A., Wolff C.R., Brown J.M. Metabolism of the bioreductive cytotoxin SR4233 by tumour cells: enzymatic studies. Br J Cancer. 67:1993;321-325.
16. Walton M.I., Wolff C.R., Workman P. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR4233, WIN59075) by mouse liver. Biochem Pharmacol. 44:1992;251-259.
17. Cahill A., White I.N.H. Reductase metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis. 11:1990;1407-1411.
18. Schor N.A., Cornelisse C.J. Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colon carcinomas. Cancer Res. 43:1983;4850-4855.
19. Schlager J.J., Powis G. Cytosolic NAD(P)H: (quinone acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer. 45:1990;403-409.
20. Cresteil T., Jaiswal A.K. High levels of expression of the NAD(P)H: quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol. 42:1991;1021-1027.
21. Smitskamp-Wilms E., Giaccone G., Pinedo H.M., Van der Laan B.F.A.M., Peters G.J. DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents? Br J Cancer. 72:1995;917-921.
22. Marin A., Lopez de Cerain A., Hamilton E., et al. DT-diaphorase and cytochrome b5 reductase in human lung and breast tumours. Br J Cancer. 76:1997;923-929.
23. American Joint Committee on Cancer (AJCC). Manual for Staging of Cancer, 4th edn. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Philadelphia, J.B. Lippincott, 1992.
24. Smith P.K., Krohn I.R., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid Anal Biochem. 150:1985;76-85.
25. Ernster L. DT-diaphorase. Methods Enzymol. 10:1967;309-317.
26. Riley R.J., Workman P. DT-diaphorase and cancer chemotherapy. Biochem Pharmacol. 43:1992;1657-1659.
27. Kuffel M.J., Reid J.M., Ames M.M. Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture. Cancer Chemother Pharmacol. 30:1992;51-57.
28. Schott B., Robert J. Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture. Biochem Pharmacol. 38:1989;4069-4074.
29. Jarabak J., Harvey R.G. Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substrates. Arch Biochem Biophys. 303:(2):1993;394-401.
30. Forrest G.L., Akman S., Krutzik S., et al. Induction of a human carbonyl reductase gene located on chromosome 21. Biochem Biophys Acta. 1048:1990;149-155.
31. McManus M.E., Boobis A.R., Pacifici G.M., et al. Xenobiotic metabolism in the human lung. Life Sci. 26:1980;481-487.